Leaflet BLOONIS 20mg orodispersible tablets


Indicated for: schizophrenia; bipolar disorder

Substance: olanzapine (antipsychotic)

ATC: N05AH03 (Nervous system | Antipsychotics | Diazepines, oxazepines, thiazepines and oxepines)

Olanzapine is an atypical antipsychotic used for the treatment of schizophrenia, bipolar disorder, and other psychiatric conditions. It works by blocking dopamine and serotonin receptors in the brain, helping to reduce psychotic symptoms and stabilize mood.

The medication is taken orally, usually once daily, as directed by a doctor. The dosage is adjusted based on the patient's response and the severity of the condition.

Patients should be aware of potential side effects, such as weight gain, drowsiness, or dizziness. It is important to inform the doctor of any unusual symptoms or the use of other medications.

Common side effects include weight gain, drowsiness, dizziness, and dry mouth. In rare cases, severe reactions such as neuroleptic malignant syndrome or hyperglycemia may occur. Patients should be informed of these risks before starting treatment.

General data about BLOONIS 20mg

  • Substance: olanzapine
  • Date of last drug list: 01-05-2026
  • Commercial code: W64079002
  • Concentration: 20mg
  • Pharmaceutical form: orodispersible tablets
  • Quantity: 28
  • Product type: generic
  • Price: 66.04 RON
  • Prescription restrictions: P-RF - Medicines prescription that is retained in the pharmacy (not renewable).

Marketing authorisation

  • Manufacturer: ZENTIVA S.A. - ROMANIA
  • Holder: ZENTIVA, K.S. - REPUBLICA CEHA
  • Number: 13324/2020/02
  • Shelf life: 2 years

Concentrations available for olanzapine

  • 10mg
  • 15mg
  • 2.5mg
  • 20mg
  • 210mg
  • 300mg
  • 405mg
  • 5mg
  • 7.5mg

Compensation lists for BLOONIS 20mg Zentiva

G15 (C1) - Mental disorders

Price

Copayment

Patient

66.04 RON

66.04 RON

0.00 RON

GX (C1) - GENERIC (used in compensation list, C1, for another diagnosis)

Price

Copayment

Patient

66.04 RON

66.04 RON

0.00 RON